AI Stock · 1 phase

RXRX — Recursion Pharma

Live: $3.15 · YTD -25.0% · as of 2026-06-11

Recursion Pharma (RXRX) appears in the Singularity Race 9-Phase AI Investment Framework in the phase below, each with its investment thesis.

Where RXRX fits

PhaseThesis
Phase 7 — AI Healthcare Revolution$665M cash runway to 2028; REC-4881 Phase 2 (53% polyp reduction); screens billions of biological images via AI
All stocksThe 9-phase map →

Educational framework, not financial advice. Tickers and theses are illustrative of each phase's investment thesis, not recommendations.